vimarsana.com

Page 2 - உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Warning Shot: Some Experts Oppose Use Of Kazakh-Produced COVID-19 Vaccine

Warning Shot: Some Experts Oppose Use Of Kazakh-Produced COVID-19 Vaccine width No media source currently available 0:00 0:02:56 0:00 Some 100,000 doses of a locally produced COVID-19 vaccine called QazVac have already been distributed in Kazakhstan before the publication of late-stage clinical trial data. Independent health experts say more data should have been released proving the vaccine works and have raised questions about the trial methodology and manufacturing process. The developer, Kazakhstan s Research Institute for Biological Safety Problems, says its shots are safe and 96 percent effective. Share

When 3rd stage of QazVac clinical trials will be finished

Vaccinations Progress Slowly in Central Asia

Advertisement Kazakhstan is a regional leader on vaccinations, but that’s not saying terribly much as vaccine rollouts across Asia have proceeded at slow paces relative to Western countries. Meanwhile, reports from Kazakhstan cite bureaucratic hurdles, hesitancy, and a lack of access to data about the country’s domestically-developed vaccine. To date around 8.3 percent of the Kazakh population, or around 1.4 million people, have received at least one dose of a COVID vaccine. That figure has grown at a steep curve in recent weeks on the back of the availability of domestically produced doses of the Russian vaccine, Sputnik V, in addition to imported doses. 

Not available in Canada: A look at COVID-19 vaccine tech from China, India and Cuba

Posted: May 04, 2021 4:00 AM ET | Last Updated: May 4 A healthcare worker prepares a dose of China s Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a drive-thru vaccination station, as a mass vaccination program continues in Jakarta, Indonesia, April 30, 2021. It s an inactivated vaccine being used in countries around the world, but not in Canada.(Ajeng Dinar Ulfiana/Reuters)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.